USFDA completes GMP inspection at Cohance Lifesciences’ Hyderabad facility

14 Aug 2025 Evaluate

United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practices (GMP) inspection at Cohance Lifesciences’ Finished Dosage Formulations Manufacturing Facility (FDF Unit-I) located in Nacharam, Hyderabad. The inspection was conducted from August 4, 2025 to August 12, 2025 excluding the weekend of August 9 and 10, 2025.

Following the inspection, the Company has received a Form 483 from the USFDA with 06 observations. These are predominantly procedural in nature. 

Cohance Lifesciences (Formerly, Suven Pharmaceuticals) is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialization. 

Cohance Lifesciences Share Price

544.20 -4.90 (-0.89%)
05-Dec-2025 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.50
Dr. Reddys Lab 1275.55
Cipla 1525.60
Zydus Lifesciences 933.80
Lupin 2101.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×